MedicalResearch.com - Latest news, interviews, and insights into medical research, health and wellness, fitness and addiction.
Aging, Author Interviews, Genetic Research / 15.07.2025

The study was done by a team of researchers at the The Hebrew University-Hadassah Medical School, led by Bracha Ochana and Daniel Nudelman, under the supervision of Prof. Tommy Kaplan, Prof. Yuval Dor and Prof. Ruth Shemer. MedicalResearch.com: What is the background for this study? Response: DNA methylation is a key epigenetic modification that annotates the human genome. It is established during development and cellular differentiation, and is associated with maintenance of cell type identity and control of gene expression. Nonetheless, few regions in the human genome change with age and serves as a powerful biomarker for estimating chronological and biological age. However, most current epigenetic clocks rely on average methylation at individual CpG sites using array-based data, which overlook complex regional patterns across neighboring methylation sites. This study aimed to understand how time and age are encoded at the molecular and cellular level, and to develop a highly accurate age predictor, based on regional methylation dynamics. MedicalResearch.com: What types of cells were used in the study, ie keratinocytes, muscle cells etc? Response: The primary tissue used in this study was peripheral blood from over 300 healthy human donors (18-78 years old). To further understand how the methylation changes are associated with changes in blood cell composition, we also sorted immune cell types including neutrophils, monocytes, B cells, and T cells. For forensics applications, we also tested the clock on urine and saliva samples.     MedicalResearch.com: Does this study relate at all to telomere length?Response: Response: No, this study does not investigate or reference telomere length. It focuses entirely on DNA methylation changes at few genomics regions, each covering multiple clustered DNA methylation sites, where methylation changes are indicative of chronological age, independently of telomere biology.   MedicalResearch.com: What are the main findings? Response:  - A single-molecule analysis using DNA sequencing, revealed that age-related methylation changes often occur regionally across multiple neighboring methylation sites, either in a stochastic or in a block-like manner. - A deep neural network model, called MAgeNet, was trained on methylation patterns from two specific genomic loci (ELOVL2 and C1orf132) and was able to predict chronological age (of held-out test-set donors) at a median accuracy of 1.36 years (for individuals under 50). - These predictions are robust to sex, smoking, BMI, and biological age markers, and accurate even from as few as 50 cells or at low-depth sequencing. - Longitudinal sampling of healthy donors at the age of 32 and 42, shows that early deviations from predicted age persist over time, suggesting that as we age, methylation changes faithfully encode the passage of time. (more…)
Author Interviews, Biomarkers, Lung Cancer / 12.07.2025

MedicalResearch.com Interview with: Gabriele Campanella, PhD Assistant Professor Windreich Department of Artificial Intelligence and Human Health Icahn School of Medicine at Mount Sinai MedicalResearch.com: What is the background for this study? Response: Lung cancer is the most lethal cancer in the US. Lung adenocarcinoma (LUAD) is the most common form of lung cancer with an incidence of over 100k per year in the US. EGFR mutations are common driver mutations in LUAD, and importantly, these mutations can be targeted by TKI therapy, which has high response rates. Because of this, EGFR testing via NGS (Next Generation Sequencing) is considered mandatory by guidelines for any LUAD diagnosis. In high-resource settings, rapid EGFR testing is done while waiting for confirmation via NGS. This is because NGS takes about 2 weeks on average, while the rapid testing has a median TAT of 2 days. Early treatment decisions could be made based on the rapid test results. Rapid tests have some important drawbacks, most notably, it exhausts tissue. In lung cancer, tissue is scarce in the first place, and up to 25% of cases, after rapid testing there is not enough tissue for NGS. In those circumstances, patients have to be biopsied again, which adds unnecessary risk for the patient. Even worse, in some cases, the NGS is never done. A non-tissue-exhaustive computational biomarker could be used instead of the tissue-based rapid test. (more…)
Accidents & Violence, Legal-Malpractice / 08.07.2025

Car Accidents and Personal Injury: What You Should Know Car accidents can happen in the blink of an eye, leaving you feeling shocked, confused, and unsure of what to do next. Whether it's a minor fender-bender or a serious crash, injuries can have long-term effects on your health, finances, and overall well-being. Understanding your rights and knowing how to handle a personal injury claim can make all the difference in getting the compensation you deserve. If you or a loved one has been injured in a car accident, don't wait. Learn how to protect yourself and take the right steps toward recovery today!

Understanding Your Legal Rights

Knowing your legal rights after a car accident is important. You have the right to seek compensation if someone else caused your injuries. This can cover medical bills, lost wages, and pain and suffering. Insurance companies may try to settle for less than you deserve. You do not have to accept their first offer. A personal injury lawyer can help you understand your options. There are time limits for filing a claim, so acting quickly is important. Protecting your rights can make a big difference in your recovery and financial future. (more…)
Author Interviews, Cancer Research / 07.07.2025

MedicalResearch.com Interview with: Hideyuki Saya, MD, PhD Director, Oncology Innovation Center Fujita Health University Toyoake, Japan MedicalResearch.com: What is the background for this study? Response: Benzaldehyde, a simple aromatic compound found in the natural aroma of almonds and apricots, has long been reported to have anticancer activity, with clinical trials even conducted in Japan in the 1980s. However, the molecular mechanism underlying its anticancer effect has remained unclear for decades. Our study was initiated by Dr. Jun Saito, whose father was one of the original researchers studying benzaldehyde. Driven by a personal motivation to clarify the scientific basis of this compound’s effect, Dr. Saito spent over a decade in our lab to finally uncover its mechanism of action. (more…)
OBGYNE, Pediatrics, USPSTF / 01.07.2025

MedicalResearch.com Interview with: Esa M. Davis, M.D., M.P.H. Vice chair, USPSTF Professor of Family and Community Medicine Senior Associate Dean of Population and Community Medicine University of Maryland School of Medicine MedicalResearch.com: What is the background for this study? What are the main findings? Response: Breastfeeding can improve the health of babies, including reducing their risk of infections and chronic diseases, and can have health benefits for nursing mothers too. To help those who choose to, and are able to, breastfeed, the Task Force continues to recommend that healthcare professionals provide interventions or referrals during pregnancy and after birth that support breastfeeding. These interventions can include education and direct guidance on how to breastfeed. (more…)
Author Interviews, Gout / 27.06.2025

MedicalResearch.com Interview with: Orrin M. Troum, MD Orrin M. Troum, MD, is a Clinical Professor of Medicine and Voluntary Faculty Member of the Division of Rheumatology Keck School of Medicine- UCLA Director, Clinical Rheumatology Research Providence St John's Hospital Santa Monica, California MedicalResearch.com: What is the background for this study? Who is more likely to develop uncontrolled gout? Response: The Phase 4, open-label FORWARD trial was designed to evaluate the safety and efficacy of less frequent, monthly dosing of KRYSTEXXA® (pegloticase) co-administered with methotrexate (MTX) in patients with uncontrolled gout. KRYSTEXXA remains the only FDA-approved therapy for this challenging condition, but with continued research like the FORWARD trial, we can further improve and evolve the treatment landscape for patients. This study reflects a broader effort to optimize gout care with approaches that are not only effective but also more sustainable in real-world settings. Uncontrolled gout happens when gout is not properly treated and uric acid levels continue to rise, which can have a damaging impact on the body beyond the pain of regular flares. Those experiencing uncontrolled gout continue to have signs and symptoms of gout despite taking oral urate-lowering medicines. (more…)
AI and HealthCare / 27.06.2025

Over the past decade, artificial intelligence (AI) and machine learning (ML) have been hailed as game-changers across multiple industries, and healthcare is no exception. From diagnostic imaging to personalized treatments, AI is transforming how we understand and treat disease. Among the most promising areas is clinical research—where AI and ML are touted as tools to make trials faster, smarter, and more efficient. But as the buzz around these technologies grows, so does skepticism. Are we really witnessing a revolution in clinical trials, or is much of the talk around AI still more hype than reality?

The Promises of AI in Clinical Research

AI’s application in clinical trials spans a wide array of use cases. One of the biggest promises lies in patient recruitment and matching. Traditional recruitment methods often lead to delays, with over 80% of trials failing to meet enrollment timelines. AI, through natural language processing (NLP) and predictive modeling, can scan electronic health records (EHRs) and other datasets to identify eligible participants with remarkable speed and accuracy. Beyond recruitment, AI is being used to optimize protocol design, predict patient dropout rates, monitor adverse events in real-time, and even simulate synthetic control arms to reduce placebo usage. Machine learning algorithms can also mine historical trial data to detect patterns or predict success probabilities, potentially saving millions in drug development costs. (more…)
Plastic Surgery / 27.06.2025

Thinking of getting plastic surgery in Australia? Here are some tips to choosing the best surgeon for your needs. Plastic surgery is a personal journey. Whether it’s for health, confidence, or recovery, your choice of personal surgeon can change your outcome.  In Australia, where safety and standards are high, finding a qualified and trustworthy professional is essential for both. It is crucial both for looks and peace of mind.  This blog is a comprehensive guide on how to find a good plastic surgeon in Australia.  (more…)
Author Interviews, Cancer Research, Chemotherapy, Melanoma, NYU / 27.06.2025

MedicalResearch.com Interview with: Tomas Kirchhoff, PhD (corresponding author) Associate ProfessorLaura and Isaac Perlmutter Cancer Center New York University School of Medicine Robert Ferguson PhD Senior Scientist at NYU Langone Medical Center Kelsey Monson, PhD Immuno-Oncology Postdoctoral Researcher Icahn School of Medicine at Mount Sinai MedicalResearch.com: What is the background for this study? Would you briefly explain how mitochondrial DNA differs from chromosomal DNA? TK: Immune checkpoint blockade has changed the way we treat several cancers, including advanced melanoma. Before these therapies, the treatment options were very limited, but now more than half of patients experience significant tumor shrinkage or disease control. KRM: Despite these advances, many patients still do not respond to treatment. One of the main challenges in cancer medicine today is to find ways to predict which patients will benefit from these therapies before treatment begins. This approach is key to personalizing care and improving outcomes. RF: Mitochondria are small structures inside our cells that produce the energy needed for cells to function. Unlike most of our DNA, mitochondrial DNA is inherited only from the mother. Scientists can categorize this mitochondrial DNA into groups called haplogroups, based on unique variations in the genetic code. These haplogroups can provide insight into how cells produce energy and may affect a person’s health or response to cancer treatment. (more…)
Technology / 26.06.2025

All energy has a price. That’s nature’s law, and biology obeys it down to the last calorie. People talk about willpower, genetics, special diets—smoke and mirrors when compared with what’s really happening behind the scenes. The truth isn’t hidden in a rare plant extract or some secret regimen known only to athletes. It sits squarely in the way human bodies burn their fuel—how sugar, fat, and sometimes, under duress, protein get selected for combustion in a biochemical lottery that never stops spinning. Unlocking the Machinery Anyone who believes metabolism is just about burning calories has missed the story completely. Metabolism deals with priorities and mood swings. Give the body a cookie, and it starts breaking down carbohydrates for fast-access energy; eat nothing for breakfast, and suddenly fat reserves come into play. Now people want numbers. Biohackers with rings or smartwatches on their wrists chase invisible signals in glucose spikes or breath patterns for certainty. The metabolism tracker uses sweat, breath, and even fingertip scans to provide minute-by-minute feedback on how well food is converted into energy. Late-night cravings and afternoon slumps are no longer mysterious. (more…)
Health Care Systems, Health Care Workers, Pharmacology / 26.06.2025

Relocating to Australia to pursue your career can be an exciting move—but it’s not without its hurdles. Between visas, licensing, and getting familiar with the Australian workplace culture, there’s a lot to take in before you can confidently step into your new role. For regulated fields like healthcare, there are often strict steps that must be followed. One such example is the pharmacist registration process in Australia, which involves qualifications assessments, exams, and sometimes bridging programs. Whether you're in healthcare, engineering, education or another field, understanding the path ahead is key to making your transition smoother—and less stressful.

Know If Your Profession Is Regulated

Before making any big decisions, find out whether your profession is regulated in Australia. Regulated professions require formal registration, often through a governing body. This isn’t just a box to tick—it can involve detailed paperwork, verified qualifications, professional reference checks, and in some cases, local assessments or tests. For those in medicine, teaching, law, or engineering, skipping this research step could delay your ability to work legally. (more…)
Addiction, addiction-treatment / 25.06.2025

Recovery isn’t just about quitting a substance—it’s about rebuilding a life. For many women, addiction is closely tied to emotional trauma, caregiving roles, and mental health struggles that often go untreated. That’s why immersive, safe, and gender-focused environments like women’s inpatient treatment can make such a powerful difference. Inpatient care allows women to step away from outside pressures and focus fully on healing. And for those who’ve tried outpatient programs or self-managed recovery without success, inpatient treatment can be the turning point.

Why Women Need Specialized Care

Addiction affects men and women differently—not just physically, but emotionally and socially. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), women are more likely to enter treatment with co-occurring disorders such as depression, anxiety, or PTSD. They’re also more likely to have experienced intimate partner violence or to carry responsibility for children. A gender-responsive inpatient program addresses these layered challenges head-on by providing:
  • A trauma-informed and emotionally safe space
  • Peer support from other women who “get it”
  • Clinicians who understand the unique stressors women face
  • Programming that incorporates both clinical and holistic healing
(more…)
Addiction, addiction-treatment / 25.06.2025

Addiction can take a toll on every part of life—relationships, careers, self-esteem, and even our sense of identity. But here’s the truth: no matter how long you’ve struggled or how far you feel you’ve fallen, recovery is possible. And it’s never too late to rebuild. At Rebuilt Treatment, we believe recovery isn’t just about quitting substances—it’s about rediscovering who you are and creating a life that feels meaningful and sustainable. If you’re searching for personalized, compassionate addiction treatment in Seattle, WA, you’re already taking that first step.

Why Rebuilding Matters in Recovery

Many people think of recovery as a return to who they were before addiction—but that’s not always the goal. For some, addiction began during adolescence or early adulthood, meaning they've never really known life without it. That’s where the idea of rebuilding comes in. Recovery allows you to:
  • Create new routines and habits
  • Reconnect with your values and passions
  • Repair or reframe important relationships
  • Build emotional resilience and self-respect
  • Rediscover purpose in your daily life
According to the Substance Abuse and Mental Health Services Administration (SAMHSA), people in recovery who engage with holistic, individualized treatment plans show higher rates of long-term success. (more…)
Fertility / 25.06.2025

When it comes to fertility treatment, there’s no such thing as a “standard” patient. Every individual’s reproductive journey is shaped by a unique blend of health history, age, hormone levels, emotional readiness, and life circumstances. That’s why personalized fertility plans are not just helpful, they’re essential. The world of reproductive medicine has evolved tremendously in the past two decades. We now understand that successful fertility treatment requires more than just a clinical checklist. While two people may receive the same diagnosis, their treatment paths can look vastly different. What works for one couple may not work for another. (more…)
Author Interviews, JAMA, Osteoporosis, USPSTF / 24.06.2025

MedicalResearch.com Interview with: Esa M. Davis, M.D., M.P.H. Vice chair, USPSTF Professor of Family and Community Medicine Senior Associate Dean of Population and Community Medicine University of Maryland School of Medicine MedicalResearch.com: What is the background for this study? What are the main findings? Response: Osteoporosis causes bones to become weak and break or fracture more easily. It is more common as people age and can lead to serious disability, chronic pain, loss of independence, and even death. The Task Force looked at the evidence and found that all women who are 65 and older should be screened for osteoporosis. Menopause causes hormone changes that affect a person's bone density and causes their bones to break down faster than they can rebuild, thereby increasing a person's risk of osteoporosis. As a result, women younger than 65 who have already gone through menopause and have at least one additional risk factor for osteoporosis should receive a formal risk assessment to determine whether they should then be screened. It's important to note that men can also get osteoporosis and have similar risk factors as women, but unfortunately there is not enough evidence to determine whether or not screening and then treating men can help prevent fractures. (more…)
Author Interviews, Brain Injury, Exercise - Fitness / 21.06.2025

MedicalResearch.com Interview with: Jenny T. Makhoul, MBS Department of Medical Education Geisinger Commonwealth School of Medicine Scranton, PA 18509 MedicalResearch.com: What is the background for this study? Response: Chronic Traumatic Encephalopathy (CTE) is a progressive neurodegenerative disorder caused by repeated head trauma, particularly in contact sports such as American football, boxing, and soccer. It was first described in 1928 as “punch drunk syndrome” and later formally named as CTE by Dr. Bennet Omalu in 2002. It is characterized by cognitive decline, mood disturbances, and motor dysfunction. Recent findings show that even teenage athletes can develop CTE, this is a growing public health issue. Despite increasing awareness, CTE remains diagnosable only post-mortem, and no effective treatments exist. Our focused review explores the sport-specific clinical presentations, neurobiological mechanisms, diagnostic challenges, and the use of rodent models to deepen our understanding and support future prevention development. (more…)
AI and HealthCare, Author Interviews, Genetic Research, Neurology / 17.06.2025

MedicalResearch.com Interview with: Prof.  Amy Kuceyeski Ph.D. Professor of Mathematics in Radiology and Neuroscience Weill Cornell Medicine MedicalResearch.com: What is the purpose of the Krankencoder tool? Response: The Krakencoder is a tool that allows us to compactly represent brain networks, or the connections between different parts of the brain. This compact representation helps us to take a step toward achieving the goal of understanding how complex human behavior, like thinking, social interactions, and emotion, arise from the complex network that is the human brain. (more…)
Author Interviews, Cancer Research, HPV / 13.06.2025

MedicalResearch.com Interview with: Pragati Advani MD, MPH, DrPH Assistant Professor of Oncology, Department of Thoracic Surgery And on faculty with the Department of Cancer Prevention and Population Sciences Roswell Park Comprehensive Cancer Center Buffalo, NY MedicalResearch.com: What is the background for this study? Response: In oncology, a study of second primary malignancy (SPM) is an emerging field that is predominantly driven by our success in identifying and treating the first primary cancers (FPCs). HPV is responsible for nearly a third of all infectious agent-related FPCs (including cancer of the oropharynx, anus, vulva, vagina, cervix and penis). Advances in diagnostic and treatment methods have resulted in improved survivorship among these patients. However, they remain at risk for developing a SPM. No studies thus far had examined the risk of SPMs after HPV-associated FPCs, stratified by cancer site and gender. (more…)
Author Interviews, Pain Research, Pharmacology / 09.06.2025

MedicalResearch.com Interview with: Prof. Alexander Binshtok PhD Cecile and Seymour Alpert Professor in Pain Research Hebrew University’s Faculty of Medicine and Center for Brain Sciences (ELSC) MedicalResearch.com: What is the background for this study? Response: Paracetamol (also known as acetaminophen) is one of the world’s most commonly used pain relievers and fever reducers, yet for decades, its precise biological mechanism has remained something of a mystery. Traditionally, scientists believed its analgesic effect stemmed from central nervous system activity—specifically through the action of its metabolite, AM404, on cannabinoid and TRPV1 receptors in the brain. (more…)
ASCO, Author Interviews, Cancer Research, General Medicine, Pediatrics / 01.06.2025

MedicalResearch.com Interview with: Alique Topalian, PhD, MPH Research Scientist Family & Community Medicine | College of Medicine University of Cincinatti MedicalResearch.com: What is the background for this study? Response: Adolescent and young adult (AYA) cancer survivors are diagnosed between the ages of 18-39. We have seen increases in cancer diagnoses in this younger population of about 1-2% per year with an estimated total increase of 30% between 2019-2030.  Adolescent and young adult (AYA) cancer survivors experience early development of chronic medical conditions compared to healthy peers. Due to their young age at diagnosis and living decades beyond treatment, they are also at higher risk for second primary malignancies (SPM) and late effects than older adult-onset cancer survivors. Primary care providers are responsible for most long-term care of survivors and many are unfamiliar with the effects of cancer treatment in younger populations. (more…)
Alcohol, ASCO, Author Interviews, Cancer Research / 01.06.2025

MedicalResearch.com Interview with: Chinmay Jani, MD Chief Fellow, Hematology & Oncology University of Miami / Jackson Health System   Gilberto Lopes, M.D. Professor, Chief, Division of Medical Oncology Associate Director for the Cancer Center and Medical Director for International Affairs Sylvester Comprehensive Cancer Center   MedicalResearch.com: What is the background for this study? Response: There is growing evidence linking alcohol consumption to increased cancer risk and mortality. This association was recently emphasized by the former U.S. Surgeon General, prompting renewed public health interest. In response to these concerns, under the mentorship of Dr. Lopes, we evaluated national trends in alcohol-associated cancer mortality using data from the Global Burden of Disease database. (more…)
Author Interviews, Cannabis, Heart Disease / 29.05.2025

MedicalResearch.com Interview with: Matthew L. Springer, Ph.D. Associate Professor of Medicine Division of Cardiology Cardiovascular Research Institute Broad Center of Regeneration Medicine and Stem Cell Research Center for Tobacco Control Research & Education Helen Diller Family Comprehensive Cancer Center University of California, San Francisco MedicalResearch.com: What is the background for this study? Response: It's been known for many years that chronic tobacco smokers have poor endothelial function, even if they have not smoked recently, and so do non-smokers who are frequently exposed to secondhand smoke.  Endothelial dysfunction, even in otherwise outwardly healthy people, is an indication of unhealthy arteries and increased risk of cardiovascular disease later in life.  I realized that many people who would presumably avoid secondhand smoke did not mind it if it came from cannabis, and I wondered if that could be true since both kinds of smoke included the thousands of chemicals that resulted from burning plant material. A number of years ago, we developed a way to study changes in endothelial function in rats, using a technique very similar to how we measure it in humans, and we saw that, as in humans, even brief exposures to secondhand smoke from tobacco impaired vascular function in the rats.  We subsequently showed that brief exposures to secondhand smoke from marijuana, and active smoking of marijuana, similarly impaired vascular function in the rats, even if the smoke was from marijuana lacking THC and the other cannabinoids.  That again raised the question of whether the endothelial dysfunction observed in human tobacco smokers would also occur in human marijuana smokers, and whether secondhand smoke from marijuana should be avoided like secondhand smoke from tobacco. These questions form the basis of our current study..  In our study, it is quite clear that chronic cannabis smokers had endothelial dysfunction similar to that of chronic tobacco smokers.  Whether frequent exposure to secondhand marijuana smoke similarly impairs endothelial function like secondhand tobacco smoke is still unknown, and that's one of the major questions we want to answer next. (more…)
Cost of Health Care, Diabetes, Pharmaceutical Companies / 28.05.2025

Reasons for the Price Increase of Insulin .jpg The price of insulin keeps on skyrocketing every year. According to the American Diabetes Association, spending on insulin tripled within a decade. By 2022, the cost had hit a staggering $22.3 billion. Between 2017 and 2022, the inflation-adjusted cost of insulin increased by 24%. This is a significant problem since millions of people suffering from Type 1 and Type 2 diabetes can’t go without the drug. Over the years, people have initiated an insulin overpricing lawsuit. In 2023, Eli Lilly settled for $13.5 million and agreed to cap its price at $35 for four years. So why is insulin so expensive in the United States, and what can you do about it? (more…)
Nutrition, Weight Research / 24.05.2025

In today's world of fad diets and miracle weight loss solutions, many are turning to medications like Ozempic for weight loss. However, nature offers several powerful approaches that can help reduce food intake naturally—without prescriptions or side effects. Let's explore how you can harness a natural alternative to Ozempic to feel satisfied with less food while still nourishing your body properly. 80Bites: The Original "Natural Ozempic" Long before weight-loss medications hit the market, the 80Bites approach pioneered the concept of portion training as the key to sustainable weight management. This methodology focuses on a simple principle: it's not just what you eat, but how much and how often that matters. The 80Bites plan gets its name from research suggesting that the human stomach is designed to comfortably process a maximum of 80 normal-sized bites of food per day. By tracking and gradually reducing your daily bite count to around this target, you naturally train your stomach to feel satisfied with less food volume and you rebalance your hormones so that leptin and ghrelin work together. Today, because of decades of dieting, obese people are abnormally hungry because their hormones malfunction. Calorie counting can lead to binging as a result of eating foods that may not satisfy but are on the diet because they are low in calories and are unlimited in terms of quantity. The 80Bites approach focuses purely on quantity. This allows you to eat the foods you enjoy. Does anyone know what kale tastes like in someone else’s mouth? (more…)
Addiction, Alcohol / 23.05.2025

“I’m Fine” Can Hide a Lot

You get up early. You’re productive at work. You show up for your family. You even go to the gym sometimes. From the outside, everything looks good. But at the end of the day—sometimes before it—you’re pouring a drink, or two, or more. Not because you’re out of control, but because it’s how you cope. Because it’s the only thing that turns down the noise. This is the reality for countless people living with high-functioning alcohol use. It doesn’t always look like rock bottom. It looks like “fine.” But fine isn’t the same as well. And managing isn’t the same as thriving. (more…)
Addiction, Mental Health Research / 23.05.2025

Mental Health Deserves Just as Much Care as Physical Health

Struggling with anxiety, depression, trauma, or other mental health challenges isn’t something to ignore or “push through.” Left untreated, these conditions can impact every part of your life—from relationships and work to physical health and daily functioning. The good news? Help is out there—and healing is possible. If you’re looking into mental health treatment centers in Georgia, you’ve already taken a brave and important first step. Now it’s about finding a center that offers real support, not just quick fixes. (more…)
Addiction / 23.05.2025

Addiction Is More Than a Substance Problem—It’s a Behavioral Health Issue

For many individuals struggling with addiction, the substance is only part of the story. Underneath the surface, there’s often a deeper battle happening—one rooted in trauma, anxiety, depression, or emotional pain that hasn’t been addressed. That’s why the most effective recovery isn’t just about getting sober—it’s about healing the mind, body, and spirit. Modern drug rehab centers in Asheville North Carolina and beyond are embracing this truth by integrating behavioral health care into every part of the recovery process. This shift is transforming outcomes and helping people find not just sobriety, but lasting stability and personal growth. (more…)
Author Interviews, Breast Cancer, Mammograms / 22.05.2025

MedicalResearch.com Interview with: Dr Tong Li PhD | Cancer Institute NSW Early Career Fellow Breast Cancer Clinical and Population Health Stream The Daffodil Centre, Faculty of Medicine and Health, The University of Sydney Moore Theological College | The University of Sydney | NSW | 2042    MedicalResearch.com: What is the background for this study? Response: Having a family history of breast cancer is one of the most common risk factors for women. About 8% to 11% of women in the U.S. report having a close relative diagnosed with breast cancer. These women often have dense breasts. Dense breast tissue can make standard digital mammography (DM, also known as 2D mammography) less effective in detecting cancer. Digital breast tomosynthesis (DBT), a 3D imaging technology, has become increasingly used in breast cancer screening because it improves the visibility of lesions and reduces unnecessary callbacks. However, until now, it has been unclear whether DBT offers the same benefits in women with a family history of breast cancer, especially across different family risk levels and breast density types. (more…)